GeneDx Holdings Corp.
WGS
$98.01
$0.740.76%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 70.25% | 81.80% | 76.22% | 74.67% | 67.98% |
Total Depreciation and Amortization | -22.41% | -38.37% | -20.41% | 16.73% | 70.56% |
Total Amortization of Deferred Charges | -- | -77.42% | -83.59% | -85.29% | -86.60% |
Total Other Non-Cash Items | 565.91% | -84.20% | -81.21% | -94.65% | -97.43% |
Change in Net Operating Assets | 35.29% | -56.59% | -179.58% | -193.01% | -212.87% |
Cash from Operations | 84.18% | 74.33% | 64.89% | 51.91% | 43.56% |
Capital Expenditure | -4.59% | 4.42% | 40.26% | 1.47% | 26.63% |
Sale of Property, Plant, and Equipment | -- | -96.22% | -88.99% | -- | -- |
Cash Acquisitions | -- | 100.00% | 100.00% | 90.44% | 90.44% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 18.85% | -4.94% | -1,476.78% | -461.91% | -323.75% |
Cash from Investing | 31.09% | 17.32% | -185.70% | 69.23% | 69.06% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 42.39% | 34.03% | 31.02% | 44.99% | -70.05% |
Issuance of Common Stock | -66.93% | -89.68% | -99.88% | -97.73% | -28.57% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -76.29% | -56.72% | -67.47% | -83.90% | -5.61% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 61.56% | 74.96% | 28.96% | -29.04% | 85.70% |